Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2022-06-15 00:00:00 ET · period of report 2022-06-14 · accession 0001628280-22-017186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-15 | 2022-06-14 | AQST | Boyd Peter E. | SVP-Bus. Process, Info. Tech | P - Purchase | $0.81 | +5,000 | 59.5K | +9% | +$4,050 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-14 | P | A | 5,000 | $0.81 | 59,532 | D | — | — | (F1) This transaction was executed in multiple transactions at the price of $0.81. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was effected. |